AMRX — Amneal Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $5.17bn
- $7.69bn
- $3.02bn
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study
U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway
U.S. STOCKS ON THE MOVE-Certara, Otis, Twilio
U.S. STOCKS ON THE MOVE-Best Buy, Teleflex, Philip Morris
U.S. STOCKS ON THE MOVE-Adobe, GE Vernova, Calix
Brief: Kashiv Biosciences Agrees To Be Acquired By Amneal Pharmaceuticals To Create A Fully Integrated Global Biosimilar Leader
Amneal rises as Kashiv BioSciences buy lifts biosimilar push, outlook
Amneal Pharma to buy Kashiv BioSciences in $1.1 billion deal
Focus: Patients scramble to find estrogen patches as shortage worsens after US FDA champions use
US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings
Amneal Pharmaceuticals Q4 revenue slightly beats on Specialty segment strength
Brief: Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit Agreement - SEC Filing
Brief: Amneal Pharma To Settle Majority Of Opioids-Related Claims
U.S. STOCKS ON THE MOVE-Amneal Pharma, Ardelyx, Snap
Amneal Pharma gains as co poised to join S&P SmallCap index
Brief: Amneal Pharma Expects To Meet Or Exceed Its 2025 Full-Year Financial Guidance